Ida Bruun K.
- Country
- Denmark
- Department
- Department of Hematology
Research Overview
- Evaluation of Safety and Pharmacokinetics of Forimtamig in Patients With Relapsed or Refractory Multiple Myeloma
- Evaluation of Safety, Tolerability, and Clinical Activity of Forimtamig-Based Combinations in Relapsed or Refractory Multiple Myeloma Patients
- A Randomized, Open-Label, Phase 3 Trial to Compare the Efficacy and Safety of Idecabtagene Vicleucel with Lenalidomide Maintenance Versus Lenalidomide Maintenance Therapy Alone in Adult Participants with Newly Diagnosed Multiple Myeloma Who Have Suboptimal Response After Autologous Stem Cell Transplantation
Data & Insights
Has run more than one trial at 66 of 147 partner sites.
Specializations
Acute Leukemias
Focused on therapeutic strategies for rapidly progressing blood cancers that require urgent intervention.
- Acute Myeloid Leukemia
- Acute Lymphoblastic Leukemia
- Philadelphia‑negative Acute Lymphoblastic Leukemia
Emphasis on targeted agents, transplant integration, and relapse prevention.
Lymphomas
Investigation of malignant lymphoid proliferations across a spectrum of clinical aggressiveness.
- Diffuse Large B‑Cell Lymphoma
- Hodgkin Lymphoma
- Mantle Cell Lymphoma
- Follicular Lymphoma
Includes both indolent and high‑grade subtypes with novel immunotherapeutic approaches.
Plasma Cell Dyscrasias
Addresses disorders of plasma cells and related amyloid deposition diseases.
- Multiple Myeloma
- Light Chain (AL) Amyloidosis
- Smoldering Multiple Myeloma
Research spans maintenance therapy, anti‑amyloid strategies, and emerging immunotherapies.
Myeloproliferative & Myelodysplastic Disorders
Studies clonal marrow diseases characterized by abnormal proliferation or ineffective hematopoiesis.
- Myelofibrosis
- Essential Thrombocythemia
- Myelodysplastic Syndrome
Explores risk stratification, disease‑modifying agents, and transplantation eligibility.
Hematologic‑Cardiovascular Intersections
Investigates the interplay between blood disorders and cardiovascular pathology.
- Atherosclerotic Cardiovascular Disease
- Thromboembolic Events
- Antiphospholipid Antibodies
Targets prevention of clotting, inflammation, and associated morbidity in hematologic patients.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.